Evidence map›Paper›PMID 29075560›Full record

ArticleBrain and behavior2017

Deletion of

Suzanne O Nolan, Conner D Reynolds, Gregory D Smith, Andrew J Holley, Brianna Escobar, Matthew A Chandler, Megan Volquardsen, Taylor Jefferson, Ashvini Pandian, Tileena Smith and 2 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Sex Differences in Brain Disorders.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Suzanne O NolanDepartment of Psychology and Neuroscience Baylor University Waco TX USA.ORCID 0000-0002-2094-8793
Conner D ReynoldsDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Gregory D SmithInstitute for Biomedical Studies Baylor University Waco TX USA.
Andrew J HolleyDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Brianna EscobarDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Matthew A ChandlerDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Megan VolquardsenDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Taylor JeffersonInstitute for Biomedical Studies Baylor University Waco TX USA.
Ashvini PandianDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Tileena SmithInstitute for Biomedical Studies Baylor University Waco TX USA.
Jessica HuebschmanDepartment of Psychology and Neuroscience Baylor University Waco TX USA.
Joaquin N LugoDepartment of Psychology and Neuroscience Baylor University Waco TX USA.ORCID 0000-0001-6874-8718
Baylor University · USUniversity of North Texas · US

Funding

Signaling Mechanisms Underlying Epilepsy and Autism CormorbidityR15NS088776 · NINDS · BAYLOR UNIVERSITY · PI JOAQUIN N LUGO · 2015 to 2026
$1.8M
NINDS NIH HHS R15 NS088776
6 · The paper itself

Abstract

objectiveIn this study, we used a systemic

backgroundFragile X syndrome is the most common monogenic cause of intellectual disability and autism. Few studies to date have examined sex differences in a mouse model of Fragile X syndrome, though clinical data support the idea of differences in both overall prevalence and phenotype between the sexes.

methodsUsing wild-type and systemic homozygous

resultsOur results indicate several sex-specific changes in

conclusionThese findings highlight the importance of including female subjects in preclinical studies, as simply studying the impact of genetic mutations in males does not yield a complete picture of the phenotype. Further research should explore these marked phenotypic differences among the sexes. Moreover, given that treatment strategies are typically equivalent between the sexes, the results highlight a potential need for sex-specific therapeutics.

Indexed as

Fragile X SyndromeAnimalsAnxietyBehavior, AnimalDisease Models, AnimalFearFemaleFragile X Messenger Ribonucleoprotein 1MaleMiceMice, Inbred C57BLMice, KnockoutMutationSex FactorsSocial BehaviorFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1anxietyautismFragile X syndromephenotypesplasticity

Identifiers

PMID29075560
PMCPMC5651384
OpenAlexW2747523346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.